Target intelligence / Profile preview

Innate immune pattern-recognition receptors sensing influenza viral RNA (PRRs)

Target
PRRs
Molecular classification
Receptor, Pattern recognition receptor, RNA helicase, Transmembrane protein
01

Overview

Innate immune pattern-recognition receptors (PRRs) that sense influenza viral RNA represent a critical class of sensors responsible for detecting the presence of viral genetic material during infection. This group primarily includes Retinoic acid-inducible gene I (RIG-I), which detects 5'-triphosphorylated or diphosphorylated short double-stranded RNA in the cytoplasm, and Toll-like receptors (TLR7 and TLR3), which sense single-stranded and double-stranded RNA within endosomes. Upon activation, these receptors initiate signaling cascades involving adaptor proteins like MAVS or MyD88, leading to the activation of transcription factors such as IRF3/7 and NF-κB. This process results in the robust production of Type I interferons and pro-inflammatory cytokines, which are essential for limiting viral replication and orchestrating the adaptive immune response. While these receptors are vital for host defense against influenza, their overactivation can contribute to severe immunopathology, such as the 'cytokine storm' observed in highly pathogenic avian influenza infections. Consequently, they are being explored as therapeutic targets for both antiviral adjuvants and immunomodulatory treatments.

Other names
Pattern recognition receptorsRNA-sensing PRRsInfluenza virus sensorsRIG-I-like receptorsToll-like receptorsNOD-like receptors
02

Mechanism of action

Agonists of these receptors (e.g., TLR7/8 or RIG-I ligands) mimic viral RNA to trigger the production of Type I interferons and pro-inflammatory cytokines, thereby enhancing the innate and adaptive immune response against viral infections or tumors.

03

Biological functions

Immune responseSignal transductionCytokine productionApoptosisAntiviral defense
04

Disease associations

InfectionInflammationAutoimmune diseaseCytokine storm
05

Safety considerations

Systemic inflammatory response syndromeCytokine release syndromeAutoimmunityInjection site reactionsFlu-like symptoms
06

Interacting drugs

Imiquimod

5 more in the full profile.

07

Biomarkers

Interferon-alpha (IFN-α)Interferon-beta (IFN-β)Interleukin-6 (IL-6)Tumor necrosis factor-alpha (TNF-α)IP-10 (CXCL10)

Beyond the preview

Go deeper on Innate immune pattern-recognition receptors sensing influenza viral RNA (PRRs).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Innate immune pattern-recognition receptors sensing influenza viral RNA (PRRs).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call